Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterized by interferon-gamma-expressing Th1 and IL-17/IL-22-expressing Th17 cell infiltrates and respond to anti-IL-12/IL-23 antibody treatment

Interferon Gamma ◽

Bowel Disease ◽

Th17 Cell ◽

Skin Lesions ◽

Antibody Treatment ◽

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Gut ◽

10.1136/gutjnl-2012-302853 ◽

2013 ◽

Vol 63 (4) ◽

pp. 567-577 ◽

Cited By ~ 156

Author(s):

Cornelia Tillack ◽

Laura Maximiliane Ehmann ◽

Matthias Friedrich ◽

Rüdiger P Laubender ◽

Pavol Papay ◽

...

Keyword(s):

Bowel Disease ◽

Th17 Cells ◽

Skin Lesions ◽

Interferon Γ ◽

Th1 Cells ◽

Antibody Treatment ◽

639 Anti-TNF Antibody-Induced Psoriasiform Skin Lesions in Patients With Inflammatory Bowel Disease Are Characterized by Interferon-y-Expressing TH1 Cells and IL-17A/IL-22-Expressing TH17 Cells and Respond to Anti-IL-12/IL-23 Antibody Treatment

Gastroenterology ◽

10.1016/s0016-5085(13)60406-0 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-112 ◽

Cited By ~ 1

Author(s):

Cornelia Tillack ◽

Laura M. Ehmann ◽

Matthias Friedrich ◽

Julia Diegelmann ◽

Jürgen Schauber ◽

...

Keyword(s):

Bowel Disease ◽

Th17 Cells ◽

Skin Lesions ◽

Th1 Cells ◽

Antibody Treatment ◽

P683. Skin lesions in patients with inflammatory bowel disease from southern Brazil: an epidemiologic study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.802 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S449.2-S449

Keyword(s):

Bowel Disease ◽

Epidemiologic Study ◽

Skin Lesions ◽

Southern Brazil ◽

Su1171 Tuberculosis Screening With Interferon-Gamma Release Assay in Inflammatory Bowel Disease in a Tuberculosis-Endemic Population

Gastroenterology ◽

10.1016/s0016-5085(13)61538-3 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-418 ◽

Cited By ~ 1

Author(s):

Sunny H. Wong ◽

Zheng Lin ◽

Margaret Ip ◽

Whitney Tang ◽

Ka Man Kee ◽

...

Keyword(s):

Interferon Gamma ◽

Bowel Disease ◽

Interferon Gamma Release Assay ◽

Tuberculosis Screening ◽

Endemic Population ◽

Release Assay ◽

Sa1224 Assessing the Performance of Interferon-Gamma Release Assays in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Gastroenterology ◽

10.1016/s0016-5085(12)60931-7 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-248

Author(s):

Neal C. Shahidi ◽

Yi - Tzu Nancy Fu ◽

Hong Qian ◽

Brian Bressler

Keyword(s):

Systematic Review ◽

Interferon Gamma ◽

Bowel Disease ◽

Meta Analysis ◽

Interferon Gamma Release Assays ◽

TRIM21 Negatively Regulates Intestinal Mucosal Inflammation through Inhibition of Th1/Th17 Cell Immune Responses in Inflammatory Bowel Disease

Gastroenterology ◽

10.1016/s0016-5085(17)30688-1 ◽

2017 ◽

Vol 152 (5) ◽

pp. S104

Author(s):

Guangxi Zhou ◽

Lin Yu ◽

Wenjing Yang ◽

Tianming Yu ◽

Liang Chen ◽

...

Keyword(s):

Immune Responses ◽

Bowel Disease ◽

Th17 Cell ◽

Mucosal Inflammation ◽

Etrolizumab. Anti-alphaEbeta7/alpha4beta7 monoclonal antibody, treatment of inflammatory bowel disease

Drugs of the Future ◽

10.1358/dof.2015.040.10.2387217 ◽

2015 ◽

Vol 40 (10) ◽

pp. 639

Author(s):

P. Cole

Keyword(s):

Monoclonal Antibody ◽

Bowel Disease ◽

Antibody Treatment ◽

Monoclonal Antibody Treatment ◽

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease

Inflammatory Bowel Diseases ◽

10.1002/ibd.20923 ◽

2009 ◽

Vol 15 (8) ◽

pp. 1133-1144 ◽

Cited By ~ 53

Author(s):

Zhanju Liu ◽

Li Yang ◽

Yi Cui ◽

Xingpeng Wang ◽

Chuanyong Guo ◽

...

Keyword(s):

Cell Differentiation ◽

Bowel Disease ◽

Th17 Cell ◽

Cell Activation ◽

Nk Cell ◽

Cytolytic Activity ◽

Th17 Cell Differentiation ◽

Author’s reply to performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients: disease activity as an influencing factor

Scandinavian Journal of Gastroenterology ◽

10.3109/00365521.2015.1093168 ◽

2015 ◽

Vol 51 (3) ◽

pp. 382-382

Author(s):

Gerassimos J. Mantzaris ◽

Konstantinos Papamichael

Keyword(s):

Disease Activity ◽

Interferon Gamma ◽

Bowel Disease ◽

Influencing Factor ◽

Interferon Gamma Release Assay ◽

Tuberculosis Screening ◽

Release Assay ◽

Anti-IL-4 antibody treatment prevents the induction of inflammatory bowel disease (IBD) in T-cell receptor (TCR) alpha chain-deficient (α−/−) mice by suppressing the effect of TH2 predominated CD4+ TCR βdim T cells

Gastroenterology ◽

10.1016/s0016-5085(98)84073-0 ◽

1998 ◽

Vol 114 ◽

pp. A1001

Author(s):

H. Iijima ◽

I. Takahashi ◽

S. Kawano ◽

K. Nagano ◽

M. Hori ◽

...

Keyword(s):

T Cells ◽

T Cell ◽

T Cell Receptor ◽

Bowel Disease ◽

Cell Receptor ◽

Antibody Treatment ◽

Alpha Chain ◽